Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21248415 | 0.90 | MAPT (0.55) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL26311955 | 0.89 | MAPT (0.59) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL31099447 | 0.86 | PDK2 (0.57) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL25245380 | 0.83 | MAPT (0.68) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL26311892 | 0.80 | FFAR4 (0.48) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL21284589 | 0.77 | MAPT (0.55) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL30526038 | 0.77 | MAPT (0.55) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| Adipic Acid SCHEMBL11061203 | 0.77 | PDE4B (0.51) | MAPTL3MBTL1ALDH1A1GAAFFAR4 | |
| SCHEMBL26902122 | 0.77 | MAPT (0.62) | MAPTKMT2AL3MBTL1MEN1NPC1 | |
| SCHEMBL11064734 | 0.76 | PPARG (0.51) | MAPTL3MBTL1ALDH1A1GAAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11724980-B2 | Quinones having high capacity retention for use as electrolytes in aqueous redox flow batteries | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11724980-B2 | Quinones having high capacity retention for use as electrolytes in aqueous redox flow batteries | NQO1, NDUFS5, NDUFS2 | MAPT 2819/4885KMT2A 3256/4885L3MBTL1 3859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.